Marketplace®
Every story is an economic story

Glaxo defends Flonase

The FDA, under fire for sluggishness in approving generic drugs, announced this week that it had OKed a generic version of the popular nasal spray Flonase. In response, the drug's maker, GlaxoSmithKline, took legal action to halt the move. Helen Palmer reports from the Health Desk at WGBH.

Related Topics

Tagged as:

Latest Episodes

View All Shows
  • Marketplace
    2 days ago
    25:28
  • Marketplace Morning Report
    3 days ago
    6:39
  • Marketplace Tech
    3 days ago
    13:02
  • This Is Uncomfortable
    4 days ago
    42:59
  • Million Bazillion
    13 days ago
    29:48
  • Make Me Smart
    5 months ago
    24:33